Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: New insight into CXCR4-FC131 interactions

被引:34
|
作者
Yoshikawa, Yasushi [1 ]
Kobayashi, Kazuya [2 ]
Oishi, Shinya [2 ]
Fujii, Nobutaka [2 ]
Furuya, Toshio [1 ,3 ]
机构
[1] PharmaDesign Inc, Div Res & Dev, Drug Discovery Dept, Chuo Ku, Tokyo 1040032, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[3] Univ Tokyo, Open Innovat Ctr Drug Discovery, Bunkyo Ku, Tokyo 1130033, Japan
关键词
FC131; CXCR4; GPCR; Docking; Molecular modeling; CHEMOKINE RECEPTOR CXCR4; HIV-1; ENTRY; BINDING; IDENTIFICATION; T140; INHIBITOR; MECHANISM; SDF-1; SCAFFOLDS; AGENTS;
D O I
10.1016/j.bmcl.2012.01.134
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
CXCR4 is a G-protein coupled receptor that is associated with many diseases such as breast cancer metastasis, HIV infection, leukemic disease and rheumatoid arthritis, and is thus considered an attractive drug target. Previously, we identified a cyclic pentapeptide, FC131, that is a potent antagonist for CXCR4. In this study, we constructed a three dimensional model of the CXCR4-FC131 complex. To investigate the backbone flexibility of FC131, we performed molecular dynamics simulations of FC131 based on the NMR structure of FC131, and obtained snapshot structures from the trajectories which were used to model the docking pose of FC131 into CXCR4. Our final model of the CXCR4-FC131 complex is partially different from the X-ray crystal structure of CXCR4-CVX15 and suggests water-mediated interactions. Nevertheless, this docking pose is consistent with the experimental data. We believe our model will aid in the discovery and development of small-molecule antagonists for CXCR4. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2146 / 2150
页数:5
相关论文
共 50 条
  • [21] Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor
    Katzman, Brooke M.
    Cox, Bryan D.
    Prosser, Anthony R.
    Alcaraz, Ana A.
    Murat, Brigitte
    Heroux, Madeleine
    Tebben, Andrew
    Zhang, Yong
    Schroeder, Gretchen M.
    Snyder, James P.
    Wilson, Lawrence J.
    Liotta, Dennis C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (01): : 67 - 73
  • [22] Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds
    Tamamura, H
    Araki, T
    Ueda, S
    Wang, ZX
    Oishi, S
    Esaka, A
    Trent, JO
    Nakashima, H
    Yamamoto, N
    Peiper, SC
    Otaka, A
    Fujii, N
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (09) : 3280 - 3289
  • [23] Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists
    Truax, Valarie M.
    Zhao, Huanyu
    Katzman, Brooke M.
    Prosser, Anthony R.
    Alcaraz, Ana A.
    Saindane, Manohar T.
    Howard, Randy B.
    Culver, Deborah
    Arrendale, Richard F.
    Gruddanti, Prahbakar R.
    Evers, Taylor J.
    Natchus, Michael G.
    Snyder, James P.
    Liotta, Dennis C.
    Wilson, Lawrence J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (11): : 1025 - 1030
  • [24] The therapeutic potential of CXCR4 antagonists in the treatment of HIV
    Fujii, N
    Nakashima, H
    Tamamura, H
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 185 - 195
  • [25] SCAFFOLD-BASED TRIPEPTIDOMIMETIC CXCR4 ANTAGONISTS
    Haug, B. E.
    Baumann, M.
    Karlshoj, S.
    Rosenkilde, M. M.
    Vabeno, J.
    JOURNAL OF PEPTIDE SCIENCE, 2016, 22 : S170 - S170
  • [26] Configurationally restricted bismacrocyclic CXCR4 receptor antagonists
    Valks, Gina C.
    McRobbie, Graeme
    Lewis, Elizabeth A.
    Hubin, Timothy J.
    Hunter, Tina M.
    Sadler, Peter J.
    Pannecouque, Christophe
    De Clercq, Erik
    Archibald, Stephen J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6162 - 6165
  • [27] SAR and Binding Mode for Cyclopentapeptide CXCR4 Antagonists
    Mungalpara, J.
    Thiele, S.
    Rosenkilde, M. M.
    Vabeno, J.
    BIOPOLYMERS, 2011, 96 (04) : 483 - 483
  • [28] Discovery of novel small molecule CXCR4 antagonists
    Greve, Daniel R.
    Nilson, Niclas
    Horneman, Anne Marie
    Blaehr, Lars
    Larsen, Jens
    Ottosen, Erik
    Sorensen, Gunnar G.
    Sorensen, Morten D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [29] CXCR4 chemokine receptor antagonists: perspectives in SCLC
    Burger, Jan A.
    Stewart, David J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 481 - 490
  • [30] SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals
    Mason, Julia
    Luyt, Len
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S202 - S203